(BIIB) Biogen - Performance -38.8% in 12m
Compare BIIB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-75.34%
#120 in Group
Rel. Strength
16.72%
#6664 in Universe
Total Return 12m
-38.83%
#89 in Group
Total Return 5y
-61.03%
#69 in Group
P/E 10.6
48th Percentile in Group
P/E Forward 7.54
40th Percentile in Group
PEG 6.24
96th Percentile in Group
FCF Yield 12.3%
94th Percentile in Group
12m Total Return: BIIB (-38.8%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: BIIB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIIB
Total Return (including Dividends) | BIIB | XBI | S&P 500 |
---|---|---|---|
1 Month | -16.55% | -10.94% | -6.73% |
3 Months | -17.75% | -14.92% | -11.93% |
12 Months | -38.83% | -6.46% | 7.24% |
5 Years | -61.03% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | BIIB | XBI | S&P 500 |
1 Month | -80.1% | -52.8% | -63.5% |
3 Months | -70.5% | -92.8% | -90.3% |
12 Months | -95.7% | -32.4% | 60.6% |
5 Years | -59.7% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #134 | -6.29% | -10.5% |
3 Month | #79 | -3.32% | -6.61% |
12 Month | #88 | -34.6% | -43.0% |
5 Years | #72 | -51.8% | -80.6% |
FAQs
Does BIIB Biogen outperforms the market?
No,
over the last 12 months BIIB made -38.83%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months BIIB made -17.75%, while XBI made -14.92%.
Over the last 3 months BIIB made -17.75%, while XBI made -14.92%.
Performance Comparison BIIB vs Indeces and Sectors
BIIB vs. Indices BIIB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.64% | -9.82% | -28.7% | -46.1% |
US NASDAQ 100 | QQQ | 0.16% | -9.19% | -28.8% | -46.4% |
US Dow Jones Industrial 30 | DIA | 2.67% | -9.64% | -29.3% | -43.3% |
German DAX 40 | DAX | -0.58% | -12.6% | -48.6% | -59.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.21% | -13.2% | -29.8% | -48.0% |
Hongkong Hang Seng | HSI | -2.03% | -12.8% | -33.2% | -55.6% |
India NIFTY 50 | INDA | -1.51% | -18.6% | -32.0% | -41.8% |
Brasil Bovespa | EWZ | -3.63% | -17.0% | -33.7% | -30.1% |
BIIB vs. Sectors BIIB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.07% | -9.70% | -37.8% | -53.9% |
Consumer Discretionary | XLY | -0.80% | -9.71% | -34.0% | -50.1% |
Consumer Staples | XLP | 0.49% | -19.5% | -36.6% | -50.2% |
Energy | XLE | 0.57% | -4.05% | -27.4% | -26.1% |
Financial | XLF | -0.06% | -11.7% | -37.5% | -56.7% |
Health Care | XLV | 2.91% | -8.79% | -26.4% | -36.4% |
Industrial | XLI | 1.24% | -10.5% | -28.5% | -42.9% |
Materials | XLB | 0.90% | -10.7% | -21.4% | -32.9% |
Real Estate | XLRE | 0.87% | -13.3% | -28.3% | -53.6% |
Technology | XLK | 0.37% | -7.55% | -22.4% | -40.0% |
Utilities | XLU | 0.75% | -16.8% | -32.3% | -60.5% |
Aerospace & Defense | XAR | 2.09% | -13.4% | -38.0% | -60.7% |
Biotech | XBI | -2.78% | -5.61% | -17.3% | -32.4% |
Homebuilder | XHB | -0.89% | -8.43% | -13.9% | -28.3% |
Retail | XRT | -1.23% | -11.2% | -25.2% | -32.5% |